On January 30, 2015 Lumendi has signed a worldwide exclusive license agreement for ESP and follow on products (ESP+/FAST) with Cornell University.
Included in this agreement is a collaboration with MINT/WeillCornell Medical College for the joint development. The team of MINT including Dr. Jeffrey W. Milsom will work closely together with Lumendi to further develop ESP; ESP* and FAST.
Thanks for opening this website about Lumendi Ltd.
I look forward to some nice posts and hope you have the slides up from this week Tuesday’s event soon.
Although your presentation was in German, I hope to be able to attend an event held in English soon.
Torsten
Dear Torsten
Thanks for your feedback and praise for our website.
Of course, we really appreciate any feedback that we can use to further improve our work 🙂
We will have the slides from Tuesday’s presentation available shortly for your perusal (on this site, of course).
We are currently considering organising another event. Maybe we do it in Geneva and this time in English. We let you know as soon as we have more news.
Thanks for sharing your thoughts.
Urs
Dear Torsten
We put the slides online here: http://lumendi.com/private-equity-investment-1/
Have a look. I find the comparison table between the more traditional approach and the endonumenal surgery particularly interesting.
I hope these are useful to you.
Looking forward to meet you at next event (in English).
Have a great weekend
Urs